Off-the-shelf universal NK products, full-factor cell culture, NK cells from peripheral blood

Antibody-cell conjugation technology

Antibody conjugation rate >90%, high stability

1 donor supports over 100 human doses

Activation of special factors

Immune domestication culture

Enhanced expression of activation receptors

Potentiated in vivo cytotoxic activity of the trained NK cells

Bifunctional molecules

Guide NK cells to target tumor cells

Utilize endogenous NK cells

Combine with universal NK cells

Carry out independent immune informatics sequence design

AI sequence optimization

Develop multi-target and multi-site mRNA vaccines to enhance the anti-tumor effect of NK cells